Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Henry J Fuchs. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Henry J Fuchs har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BMRN / BioMarin Pharmaceutical Inc. | President, Worldwide R&D | 185 074 |
US:MRTX / Mirati Therapeutics, Inc. | Director | 10 465 |
US:GHDX / Genomic Health, Inc. | Director | 0 |
US:RDEA / Ardea Biosciences, Inc. | Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Henry J Fuchs. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Henry J Fuchs som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −12 098 | 185 074 | −6,14 | 84,90 | −1 027 120 | 15 712 783 | |
2024-09-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 300 | 197 172 | 0,15 | 68,65 | 20 594 | 13 535 069 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −33 485 | 196 872 | −14,54 | 83,87 | −2 808 387 | 16 511 655 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 18 240 | 230 357 | 8,60 | ||||
2024-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −35 341 | 212 117 | −14,28 | 85,18 | −3 010 396 | 18 068 423 | |
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 238 | 247 458 | 3,88 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 326 | 238 220 | 5,93 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 30 640 | 224 894 | 15,77 | ||||
2023-12-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 17 750 | 194 254 | 10,06 | ||||
2023-12-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 317 | 176 504 | 0,18 | 66,88 | 21 200 | 11 804 235 | |
2023-08-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 000 | 176 187 | −6,38 | 90,43 | −1 085 111 | 15 931 868 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −36 000 | 188 187 | −16,06 | 93,41 | −3 362 760 | 17 578 548 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 799 | 224 187 | −2,10 | 87,74 | −421 064 | 19 670 167 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 840 | 228 986 | 7,94 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 392 | 212 146 | 6,74 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 18 220 | 198 754 | 10,09 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 36 440 | 180 534 | 25,29 | ||||
2023-02-10 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 144 094 | 0,24 | 62,41 | 21 281 | 8 992 474 | |
2023-01-24 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 4 444 | 10 465 | 73,81 | ||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 259 | 143 753 | −1,55 | 80,72 | −182 346 | 11 603 742 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 35 830 | 35 830 | |||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −12 101 | 146 012 | −7,65 | 78,27 | −947 145 | 11 428 359 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 38 790 | 158 113 | 32,51 | ||||
2022-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 840 | 119 323 | 12,06 | ||||
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −5 000 | 0 | −100,00 | |||
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −6 000 | 0 | −100,00 | |||
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −210 | 6 021 | −3,37 | 106,34 | −22 332 | 640 277 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −8 700 | 6 231 | −58,27 | 105,80 | −920 428 | 659 217 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −2 090 | 14 931 | −12,28 | 104,76 | −218 958 | 1 564 240 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 5 000 | 17 021 | 41,59 | 20,54 | 102 700 | 349 611 |
2022-02-14 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 6 000 | 12 021 | 99,65 | 20,54 | 123 240 | 246 911 |
2022-02-11 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 106 483 | 0,32 | 62,41 | 21 281 | 6 645 285 | |
2022-01-18 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
A - Award | 3 688 | 3 688 | |||||
2022-01-18 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 2 546 | 6 021 | 73,27 | ||||
2021-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 454 | 106 142 | −2,26 | 78,52 | −192 688 | 8 334 270 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 259 | 108 596 | −2,04 | 77,21 | −174 417 | 8 384 697 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 37 710 | 37 710 | |||||
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 460 | 110 855 | −6,31 | 78,39 | −584 789 | 8 689 923 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 320 | 118 315 | 14,87 | ||||
2021-01-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
A - Award | 2 155 | 2 155 | |||||
2021-01-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 1 475 | 3 475 | 73,75 | ||||
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −10 000 | 6 000 | −62,50 | |||
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −40 | 2 000 | −1,96 | 237,90 | −9 516 | 475 800 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −451 | 2 040 | −18,11 | 237,36 | −107 049 | 484 212 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 821 | 2 491 | −42,23 | 235,19 | −428 284 | 585 862 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −610 | 4 312 | −12,39 | 234,27 | −142 907 | 1 010 188 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −4 461 | 4 922 | −47,54 | 233,40 | −1 041 207 | 1 148 806 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 399 | 9 383 | −12,98 | 232,01 | −324 576 | 2 176 909 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 218 | 10 782 | −10,15 | 230,19 | −280 368 | 2 481 882 |
2020-12-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 10 000 | 12 000 | 500,00 | 20,54 | 205 400 | 246 480 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
M - Exercise | X | −10 000 | 5 000 | −66,67 | |||
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 2 000 | −20,00 | 133,07 | −66 536 | 266 144 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −5 800 | 2 500 | −69,88 | 132,34 | −767 568 | 330 848 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 300 | 8 300 | −13,54 | 131,08 | −170 408 | 1 087 986 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −1 000 | 9 600 | −9,43 | 129,80 | −129 803 | 1 246 109 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −900 | 10 600 | −7,83 | 128,56 | −115 707 | 1 362 771 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | X | −500 | 11 500 | −4,17 | 127,52 | −63 762 | 1 466 526 |
2020-08-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
M - Exercise | X | 10 000 | 12 000 | 500,00 | 20,54 | 205 400 | 246 480 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −49 423 | 0 | −100,00 | |||
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −75 716 | 0 | −100,00 | |||
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −1 250 | 0 | −100,00 | |||
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −126 389 | 102 995 | −55,10 | 130,00 | −16 430 570 | 13 389 350 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 49 423 | 229 384 | 27,46 | 63,10 | 3 118 591 | 14 474 130 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 75 716 | 179 961 | 72,63 | 67,81 | 5 134 302 | 12 203 155 |
2020-07-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 250 | 104 245 | 1,21 | 67,81 | 84 762 | 7 068 853 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −8 977 | 49 423 | −15,37 | |||
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −13 810 | 75 716 | −15,43 | |||
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −224 | 1 250 | −15,20 | |||
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −23 011 | 102 995 | −18,26 | 130,00 | −2 991 430 | 13 389 350 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 8 977 | 126 006 | 7,67 | 63,10 | 566 449 | 7 950 979 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 13 810 | 117 029 | 13,38 | 67,81 | 936 456 | 7 935 736 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 224 | 103 219 | 0,22 | 67,81 | 15 189 | 6 999 280 |
2020-07-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 339 | 102 995 | 0,33 | 62,59 | 21 217 | 6 446 045 | |
2020-04-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 680 | 102 656 | −2,54 | 97,32 | −260 813 | 9 990 318 |
2020-04-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 678 | 105 336 | −3,37 | 96,85 | −356 211 | 10 201 707 |
2020-04-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −13 642 | 109 014 | −11,12 | 95,34 | −1 300 593 | 10 393 111 |
2020-04-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −17 213 | 122 656 | −12,31 | 90,00 | −1 549 170 | 11 039 040 |
2020-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 836 | 139 869 | −4,01 | 73,05 | −426 320 | 10 217 430 | |
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 51 970 | 51 970 | |||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 18 220 | 145 705 | 14,29 | ||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −10 496 | 127 485 | −7,61 | 84,50 | −886 912 | 10 772 482 | |
2020-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 136 | 137 981 | 10,52 | ||||
2020-01-07 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2020-01-07 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
A - Award | 2 000 | 2 000 | |||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −6 583 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
D - Sale to Issuer | −955 | 0 | −100,00 | ||||
2019-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
D - Sale to Issuer | −6 878 | 955 | −87,81 | ||||
2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 185 | 7 833 | 2,42 | 67,28 | 12 447 | 527 004 | |
2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 212 | 7 648 | 2,85 | 58,86 | 12 478 | 450 161 | |
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 6 583 | 6 583 | |||||
2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 955 | 7 436 | 14,74 | ||||
2019-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 124 845 | 0,25 | 68,78 | 21 254 | 8 587 089 | |
2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 149 | 6 481 | 2,35 | 66,84 | 9 959 | 433 190 | |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 932 | 124 536 | −4,55 | 87,86 | −521 186 | 10 941 733 |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 836 | 130 468 | −4,28 | 88,05 | −513 860 | 11 487 707 | |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −9 597 | 136 304 | −6,58 | 94,09 | −902 982 | 12 824 843 |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 32 160 | 32 160 | |||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 840 | 145 901 | 9,65 | ||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −9 443 | 133 061 | −6,63 | 94,53 | −892 647 | 12 578 256 | |
2019-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 196 | 142 504 | −1,52 | 95,00 | −208 620 | 13 537 880 |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 154 | 144 700 | −0,79 | 94,76 | −109 353 | 13 711 772 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 687 | 145 854 | 12,05 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
M - Exercise | −3 521 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −521 | 6 332 | −7,60 | 79,80 | −41 577 | 505 302 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −3 000 | 6 853 | −30,45 | 78,88 | −236 650 | 540 587 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 3 521 | 9 853 | 55,61 | 27,75 | 97 708 | 273 421 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
M - Exercise | −6 479 | 3 521 | −64,79 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
M - Exercise | −20 000 | 0 | −100,00 | ||||
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −510 | 6 332 | −7,45 | 82,25 | −41 945 | 520 778 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −14 490 | 6 842 | −67,93 | 81,70 | −1 183 887 | 559 017 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | −11 479 | 21 332 | −34,99 | 82,11 | −942 572 | 1 751 628 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 6 479 | 32 811 | 24,61 | 27,75 | 179 792 | 910 505 | |
2019-02-26 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 20 000 | 26 332 | 315,86 | 33,67 | 673 400 | 886 598 | |
2019-01-22 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 155 | 6 332 | 2,51 | 64,41 | 9 984 | 407 844 | |
2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 142 | 6 177 | 2,35 | 70,18 | 9 966 | 433 502 | |
2018-08-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 500 | 130 167 | −8,76 | 100,00 | −1 250 000 | 13 016 700 | |
2018-08-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 500 | 142 667 | −8,06 | 99,00 | −1 237 500 | 14 124 033 | |
2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 198 | 6 035 | 3,39 | 50,40 | 9 979 | 304 164 | |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −20 681 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −1 875 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 669 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −3 775 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 000 | 0 | −100,00 | |||
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 681 | 155 167 | −11,76 | 90,00 | −1 861 375 | 13 965 666 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 681 | 175 848 | 13,33 | 37,46 | 774 710 | 6 587 266 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 875 | 155 167 | −1,19 | 90,00 | −168 750 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 875 | 157 042 | 1,21 | 26,49 | 49 669 | 4 160 043 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 669 | 155 167 | −1,69 | 90,00 | −240 210 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 669 | 157 836 | 1,72 | 37,46 | 99 981 | 5 912 537 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 775 | 155 167 | −2,38 | 90,00 | −339 750 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 775 | 158 942 | 2,43 | 26,49 | 100 000 | 4 210 374 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 000 | 155 167 | −1,27 | 90,00 | −180 000 | 13 965 030 |
2018-06-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 000 | 157 167 | 1,29 | 21,51 | 43 020 | 3 380 662 |
2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 934 | 155 167 | −1,23 | 92,07 | −178 063 | 14 286 226 | |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 157 101 | 0,20 | 68,78 | 21 254 | 10 805 721 | |
2018-04-27 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 835 | 156 653 | −3,59 | 81,36 | −474 736 | 12 745 288 | |
2018-04-26 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 463 | 154 024 | 15,32 | ||||
2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 319 | 5 837 | 5,78 | 31,29 | 9 982 | 182 640 | |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −6 650 | 20 681 | −24,33 | |||
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −3 350 | 1 875 | −64,11 | |||
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 650 | 156 676 | −4,07 | 80,12 | −532 798 | 12 552 881 |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 6 650 | 163 326 | 4,24 | 37,46 | 249 109 | 6 118 192 |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 350 | 156 676 | −2,09 | 80,12 | −268 402 | 12 552 881 |
2018-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 3 350 | 160 026 | 2,14 | 26,49 | 88 742 | 4 239 089 |
2018-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 812 | 156 676 | −3,58 | 81,36 | −472 864 | 12 747 159 | |
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 51 300 | 51 300 | |||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 16 040 | 162 488 | 10,95 | ||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −4 861 | 146 448 | −3,21 | 83,57 | −406 234 | 12 238 659 | |
2018-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 576 | 151 309 | −1,67 | 79,86 | −205 719 | 12 083 537 | |
2018-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 324 | 153 885 | 15,22 | ||||
2018-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −415 | 133 561 | −0,31 | ||||
2018-01-22 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | X | −10 000 | 27 331 | −26,79 | |||
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
M - Exercise | X | −5 000 | 5 225 | −48,90 | |||
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 133 976 | −10,07 | 89,23 | −1 338 400 | 11 954 236 |
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 148 976 | 7,20 | 37,46 | 374 600 | 5 580 641 |
2018-01-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 138 976 | 3,73 | 26,49 | 132 450 | 3 681 474 |
2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 292 | 5 518 | 5,59 | 34,20 | 9 986 | 188 716 | |
2017-10-13 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
J - Other | 0 | 88 515 | 0,00 | ||||
2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 311 | 5 226 | 6,33 | 32,09 | 9 980 | 167 702 | |
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 000 | 37 934 | −20,86 | |||
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 000 | 10 225 | −32,84 | |||
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 136 422 | −9,91 | 90,50 | −1 357 500 | 12 346 191 |
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 151 422 | 7,07 | 37,46 | 374 600 | 5 672 268 |
2017-09-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 141 422 | 3,67 | 26,49 | 132 450 | 3 746 269 |
2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 307 | 4 915 | 6,66 | 32,55 | 9 993 | 159 983 | |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −603 | 47 331 | −1,26 | |||
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −603 | 136 422 | −0,44 | 90,00 | −54 270 | 12 277 980 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 603 | 137 025 | 0,44 | 37,46 | 22 588 | 5 132 956 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −9 397 | 47 934 | −16,39 | |||
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 000 | 15 225 | −24,72 | |||
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −9 397 | 136 422 | −6,44 | 90,00 | −845 730 | 12 277 980 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 145 819 | −3,32 | 90,00 | −450 000 | 13 123 710 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 9 397 | 150 819 | 6,64 | 37,46 | 352 012 | 5 649 680 |
2017-06-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 141 422 | 3,67 | 26,49 | 132 450 | 3 746 269 |
2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2017-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 136 422 | −1,47 | 90,72 | −184 706 | 12 376 204 | |
2017-05-19 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 138 458 | −1,45 | 91,50 | −186 294 | 12 668 907 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 302 | 140 494 | 0,22 | 70,30 | 21 232 | 9 877 290 | |
2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 317 | 4 608 | 7,39 | 31,49 | 9 982 | 145 106 | |
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 64 030 | 64 030 | |||||
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 19 790 | 140 192 | 16,44 | ||||
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 116 | 120 402 | −4,08 | 92,50 | −473 230 | 11 137 185 | |
2017-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 924 | 125 518 | −2,28 | 93,95 | −274 710 | 11 792 416 | |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −15 000 | 20 225 | −42,58 | |||
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 128 442 | −10,46 | 87,99 | −1 319 850 | 11 301 612 |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 143 442 | 11,68 | 26,49 | 397 350 | 3 799 779 |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 14 564 | 128 442 | 12,79 | ||||
2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 340 | 4 291 | 8,61 | 29,39 | 9 993 | 126 112 | |
2016-11-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −15 000 | 35 225 | −29,87 | |||
2016-11-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 113 878 | −11,64 | 87,40 | −1 310 988 | 9 952 846 |
2016-11-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 128 878 | 13,17 | 26,49 | 397 350 | 3 413 978 |
2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 345 | 3 951 | 9,57 | 28,92 | 9 977 | 114 263 | |
2016-08-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock (Right to buy Common Stock) |
M - Exercise | X | −15 000 | 50 225 | −23,00 | |||
2016-08-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 000 | 113 878 | −11,64 | 95,06 | −1 425 924 | 10 825 425 |
2016-08-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 128 878 | 13,17 | 26,49 | 397 350 | 3 413 978 |
2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 373 | 3 606 | 11,54 | 26,74 | 9 974 | 96 424 | |
2016-06-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2016-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 113 878 | −1,76 | 90,00 | −183 240 | 10 249 020 | |
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock (Right to buy Common Stock) |
M - Exercise | −15 000 | 65 225 | −18,70 | ||||
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 115 914 | −4,14 | 87,34 | −436 700 | 10 123 929 | |
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −10 000 | 120 914 | −7,64 | 88,04 | −880 400 | 10 645 269 | |
2016-05-31 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 15 000 | 130 914 | 12,94 | 26,49 | 397 350 | 3 467 912 | |
2016-05-19 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2016-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 115 914 | −1,73 | 82,71 | −168 398 | 9 587 247 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 131 | 117 950 | −2,59 | 80,80 | −252 985 | 9 530 360 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 415 | 121 081 | 0,34 | 51,26 | 21 275 | 6 207 096 | |
2016-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 392 | 3 233 | 13,80 | 25,48 | 9 988 | 82 377 | |
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
A - Award | 44 340 | 44 340 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 19 790 | 120 666 | 19,62 | ||||
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 043 | 100 876 | −2,93 | 89,57 | −272 562 | 9 035 463 | |
2016-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −56 464 | 103 919 | −35,21 | 81,87 | −4 622 708 | 8 507 849 | |
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 7 437 | 160 383 | 4,86 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 59 520 | 152 946 | 63,71 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 580 | 93 426 | 28,25 | ||||
2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 2 841 | 11,11 | 35,20 | 9 997 | 100 003 | |
2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 468 | 2 557 | 22,40 | 21,34 | 9 987 | 54 566 | |
2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 365 | 2 089 | 21,17 | 27,34 | 9 979 | 57 113 | |
2015-06-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 864 | 72 846 | −2,49 | 122,32 | −228 001 | 8 910 384 |
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 74 710 | −2,65 | 120,46 | −245 257 | 8 999 567 | |
2015-05-22 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 864 | 76 746 | −2,37 | 124,78 | −232 584 | 9 576 105 |
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 78 610 | −2,52 | 122,78 | −249 980 | 9 651 736 | |
2015-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 434 | 80 646 | −1,75 | 121,37 | −174 038 | 9 787 626 |
2015-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 566 | 82 080 | −1,87 | 121,09 | −189 627 | 9 939 067 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 869 | 83 646 | −3,32 | 121,64 | −348 988 | 10 174 791 |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 131 | 86 515 | −3,49 | 121,66 | −380 917 | 10 525 415 | |
2015-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | 414 | 89 646 | 0,46 | 114,59 | 47 442 | 10 272 903 |
2015-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 1 425 | 90 060 | 1,61 | 51,26 | 73 050 | 4 616 791 | |
2015-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 328 | 1 724 | 23,50 | 30,43 | 9 981 | 52 461 | |
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −5 845 | 2 000 | −74,51 | |||
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −34 155 | 0 | −100,00 | |||
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −41 315 | 88 635 | −31,79 | 123,57 | −5 105 166 | 10 952 352 |
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 845 | 129 950 | 4,71 | 21,51 | 125 726 | 2 795 224 |
2015-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 34 155 | 124 105 | 37,97 | 21,51 | 734 674 | 2 669 499 |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 30 500 | 30 500 | |||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 400 | 89 950 | 17,50 | ||||
2015-01-28 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 434 | 63 415 | −2,21 | 58,23 | −83 498 | 3 692 491 | |
2015-01-28 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 001 | 64 849 | −4,42 | 59,30 | −177 959 | 3 845 546 | |
2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 312 | 1 396 | 28,78 | 31,97 | 9 975 | 44 630 | |
2014-11-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −20 000 | 34 155 | −36,93 | ||||
2014-11-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −20 000 | 76 550 | −20,71 | 86,55 | −1 730 982 | 6 625 334 | |
2014-11-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 20 000 | 96 550 | 26,13 | 21,51 | 430 200 | 2 076 790 | |
2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 350 | 1 084 | 47,68 | 28,54 | 9 989 | 30 937 | |
2014-09-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2014-09-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2014-09-11 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Option Grant (Right to Buy) |
A - Award | 16 000 | 16 000 | |||||
2014-08-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 000 | 54 155 | −15,59 | |||
2014-08-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 76 550 | −11,55 | 65,00 | −650 000 | 4 975 750 |
2014-08-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 86 550 | 13,06 | 21,51 | 215 100 | 1 861 690 |
2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 358 | 734 | 95,21 | 27,86 | 9 974 | 20 449 | |
2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock option (right to buy) common stock |
A - Award | 58 400 | 58 400 | |||||
2014-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 600 | 76 550 | 25,59 | ||||
2014-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 864 | 60 950 | −2,97 | 56,86 | −105 994 | 3 465 861 | |
2014-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 036 | 62 814 | −3,14 | 57,44 | −116 948 | 3 608 036 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 434 | 64 850 | −2,16 | 58,23 | −83 498 | 3 776 047 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 566 | 66 284 | −2,31 | 59,30 | −92 864 | 3 930 641 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −3 479 | 67 850 | −4,88 | 57,91 | −201 474 | 3 929 295 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 521 | 71 329 | −3,41 | 56,78 | −143 142 | 4 050 061 | |
2014-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −715 | 73 850 | −0,96 | 59,67 | −42 666 | 4 406 881 | |
2014-05-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 715 | 74 565 | 0,97 | 29,69 | 21 228 | 2 213 835 | |
2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 376 | 376 | 26,57 | 9 990 | 9 990 | ||
2014-02-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 31 500 | 73 850 | 74,38 | ||||
2014-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −10 000 | 64 155 | −13,49 | |||
2014-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 42 350 | −19,10 | 67,70 | −676 966 | 2 866 951 |
2014-02-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 52 350 | 23,61 | 21,51 | 215 100 | 1 126 048 |
2014-01-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −916 | 42 350 | −2,12 | 68,97 | −63 172 | 2 920 672 |
2013-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
2013-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 43 266 | −18,77 | 80,19 | −801 900 | 3 469 501 |
2013-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 53 266 | 23,11 | 11,05 | 110 500 | 588 589 |
2013-09-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2013-09-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
D - Sale to Issuer | −10 000 | 10 000 | −50,00 | ||||
2013-09-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 43 266 | −18,77 | 70,00 | −700 000 | 3 028 620 |
2013-09-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 53 266 | 23,11 | 11,05 | 110 500 | 588 589 |
2013-07-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy Common Stock) |
D - Sale to Issuer | −10 000 | 20 000 | −33,33 | ||||
2013-07-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 43 266 | −18,77 | 60,00 | −600 000 | 2 595 960 |
2013-07-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 53 266 | 23,11 | 11,05 | 110 500 | 588 589 |
2013-06-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 098 | 43 266 | −2,47 | 58,32 | −64 036 | 2 523 295 |
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −8 710 | 44 364 | −16,41 | 67,16 | −584 981 | 2 979 575 |
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
D - Sale to Issuer | −10 000 | 30 000 | −25,00 | ||||
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −11 899 | 53 074 | −18,31 | 65,66 | −781 240 | 3 484 621 |
2013-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 64 973 | 18,19 | 11,05 | 110 500 | 717 952 |
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 91 000 | 91 000 | |||||
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 600 | 54 973 | 39,62 | ||||
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 001 | 39 373 | −7,08 | 67,68 | −203 108 | 2 664 765 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 131 | 42 374 | −6,88 | 65,32 | −204 517 | 2 767 870 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 916 | 45 505 | 2,05 | 22,20 | 20 340 | 1 010 439 | |
2013-05-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −20 000 | 40 000 | −33,33 | ||||
2013-05-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −20 000 | 44 589 | −30,97 | 63,29 | −1 265 800 | 2 822 038 | |
2013-05-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 20 000 | 64 589 | 44,85 | 11,05 | 221 000 | 713 708 | |
2013-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 908 | 44 589 | −4,10 | 59,61 | −113 736 | 2 657 950 | |
2013-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 101 | 46 497 | −2,31 | ||||
2013-02-13 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 101 | 46 497 | −2,31 | ||||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 286 000 | −3,38 | |||
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 52 277 | −16,06 | 46,00 | −460 000 | 2 404 742 |
2012-11-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 10 000 | 62 277 | 19,13 | 11,05 | 110 500 | 688 161 |
2012-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 296 000 | −1,66 | |||
2012-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 37,08 | −185 384 | 1 938 264 |
2012-11-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-10-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 301 000 | −1,63 | |||
2012-10-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 39,75 | −198 760 | 2 078 110 |
2012-10-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-09-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 306 000 | −1,61 | |||
2012-09-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 37,76 | −188 790 | 1 973 880 |
2012-09-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-08-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | −5 000 | 311 000 | −1,58 | |||
2012-08-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 38,63 | −193 145 | 2 019 408 |
2012-08-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −15 000 | 316 000 | −4,53 | ||||
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 40,56 | −202 808 | 2 120 434 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −10 000 | 57 277 | −14,86 | 40,00 | −400 000 | 2 291 080 |
2012-07-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 000 | 67 277 | 28,69 | 11,05 | 165 750 | 743 411 |
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 15,53 | −194 125 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 6,03 | −75 375 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 17,71 | −221 375 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −5 000 | 0 | −100,00 | 19,84 | −99 200 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −2 500 | 0 | −100,00 | 19,84 | −49 600 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 19,84 | −248 000 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −1 250 | 0 | −100,00 | 18,81 | −23 512 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −1 250 | 0 | −100,00 | 18,12 | −22 650 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −12 500 | 0 | −100,00 | 16,31 | −203 875 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −11 729 | 0 | −100,00 | 27,76 | −325 597 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −8 193 | 0 | −100,00 | 28,50 | −233 500 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −54 468 | 0 | −100,00 | 18,94 | −1 031 624 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −27 467 | 0 | −100,00 | 15,51 | −426 013 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −4 362 | 0 | −100,00 | 15,51 | −67 655 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −220 | 0 | −100,00 | 29,24 | −6 433 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −13 644 | 0 | −100,00 | 29,24 | −398 951 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | −7 975 | 0 | −100,00 | 29,24 | −233 189 | ||
2012-06-20 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | −10 416 | 0 | −100,00 | 32,00 | −333 312 | ||
2012-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 331 000 | −1,49 | ||||
2012-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 52 277 | −8,73 | 35,02 | −175 078 | 1 830 505 |
2012-06-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 57 277 | 9,56 | 11,05 | 55 250 | 632 911 |
2012-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 741 | 52 277 | −3,22 | 38,64 | −67 279 | 2 020 187 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 60 000 | 336 000 | 21,74 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 24 000 | 54 018 | 79,95 | ||||
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy |
M - Exercise | X | −5 000 | 276 000 | −1,78 | |||
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 30 018 | −14,28 | 34,99 | −174 950 | 1 050 330 |
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 35 018 | 16,66 | 11,05 | 55 250 | 386 949 |
2012-05-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 1 098 | 30 018 | 3,80 | 19,35 | 21 242 | 580 728 | |
2012-04-26 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
M - Exercise | X | −10 000 | 7 975 | −55,63 | |||
2012-04-26 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
S - Sale | X | −10 000 | 10 416 | −48,98 | 31,64 | −316 432 | 329 596 |
2012-04-26 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
M - Exercise | X | 10 000 | 20 416 | 96,01 | 2,76 | 27 600 | 56 348 |
2012-04-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −7 691 | 28 920 | −21,01 | 35,00 | −269 185 | 1 012 200 |
2012-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 281 000 | −1,75 | ||||
2012-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 36 611 | −12,02 | 34,08 | −170 380 | 1 247 556 |
2012-04-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 41 611 | 13,66 | 11,05 | 55 250 | 459 802 |
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | −2 500 | 286 000 | −0,87 | ||||
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 36 611 | −6,39 | 34,75 | −86 883 | 1 272 349 |
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 39 111 | 6,83 | 11,05 | 27 625 | 432 177 |
2012-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 156 | 36 611 | 0,43 | 13,23 | 2 063 | 484 217 | |
2012-01-05 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
A - Award | 12 500 | 12 500 | |||||
2010-07-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
M - Exercise | X | 833 | 233 667 | 0,36 | |||
2010-07-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −833 | 31 000 | −2,62 | 20,00 | −16 660 | 620 000 |
2010-07-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 833 | 31 833 | 2,69 | 11,05 | 9 205 | 351 755 |